Cargando…

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease

BACKGROUND: The association between vedolizumab (VDZ) exposure and treatment response is unclear and seems insufficiently explained by serum levels. The aim of this study was to assess the correlation between VDZ concentrations in serum and intestinal tissue and their association with mucosal inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pauwels, Renske W M, Proietti, Elisa, van der Woude, Christien J, Oudijk, Lindsey, Crombag, Marie-Rose B S, Peppelenbosch, Maikel P, Grohmann, Ursula, Fuhler, Gwenny M, de Vries, Annemarie C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Basic Science Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528144/ https://www.ncbi.nlm.nih.gov/pubmed/33705545 http://dx.doi.org/10.1093/ibd/izab053

Ejemplares similares

Ustekinumab Tissue and Serum Levels in Patients With Crohn’s Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction
por: Proietti, Elisa, et al.
Publicado: (2022)

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
por: Pauwels, Renske W. M., et al.
Publicado: (2020)

Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice
por: Proietti, Elisa, et al.
Publicado: (2023)

Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice
por: Pauwels, Renske Wilhelmina Maria, et al.
Publicado: (2020)

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models
por: van der Giessen, Janine, et al.
Publicado: (2019)

Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis
por: Peppelenbosch, Maikel P, et al.
Publicado: (2019)

Drug Discovery in Liver Disease Using Kinome Profiling
por: Yu, Bingting, et al.
Publicado: (2021)

Overlapping cytokines in H. pylori infection and gastric cancer: A tandem meta-analysis
por: Yu, Bingting, et al.
Publicado: (2023)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
por: Lie, Mitchell R. K. L., et al.
Publicado: (2018)

Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma
por: Wang, Wenhui, et al.
Publicado: (2016)

Modulation of cytokine patterns and microbiome during pregnancy in IBD
por: van der Giessen, Janine, et al.
Publicado: (2020)

Peripheral Neutrophil Functions and Cell Signalling in Crohn`s Disease
por: Somasundaram, Rajesh, et al.
Publicado: (2013)

Colorectal Cancer Cell-Derived Small Extracellular Vesicles Educate Human Fibroblasts to Stimulate Migratory Capacity
por: Clerici, Stefano Piatto, et al.
Publicado: (2021)

Platelets in aging and cancer—“double-edged sword”
por: Faria, Alessandra V. S., et al.
Publicado: (2020)

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
por: van der Giessen, Janine, et al.
Publicado: (2019)

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
por: Deuring, J. Jasper, et al.
Publicado: (2019)

Pancreatic cyst fluid harbors a unique microbiome
por: Li, Shan, et al.
Publicado: (2017)

Technical challenges regarding the use of formalin-fixed paraffin embedded (FFPE) tissue specimens for the detection of bacterial alterations in colorectal cancer
por: Lam, Suk Yee, et al.
Publicado: (2021)

Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids
por: Utomo, Wesley K., et al.
Publicado: (2017)

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry – Vedolizumab
por: Biemans, Vince B.C., et al.
Publicado: (2019)

Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation
por: Hoekstra, Elmer, et al.
Publicado: (2016)

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease
por: Nuij, V. J. A. A., et al.
Publicado: (2017)

Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
por: Lieshout, Ruby, et al.
Publicado: (2022)

Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma
por: Nesteruk, Kateryna, et al.
Publicado: (2022)

Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
por: Proietti, E, et al.
Publicado: (2021)

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome
por: Hoekstra, Elmer, et al.
Publicado: (2016)

Analysis of SHIP1 expression and activity in Crohn’s disease patients
por: Somasundaram, Rajesh, et al.
Publicado: (2017)

Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF)
por: Eppinga, Hester, et al.
Publicado: (2017)

Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spots
por: Scholma, Jetse, et al.
Publicado: (2016)

Biotech-Educated Platelets: Beyond Tissue Regeneration 2.0
por: Andrade, Sheila Siqueira, et al.
Publicado: (2020)

Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease
por: Loganes, Claudia, et al.
Publicado: (2016)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer
por: Hoekstra, Elmer, et al.
Publicado: (2015)

Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
por: Gabriëls, Ruben Y., et al.
Publicado: (2022)

Human mesenchymal stromal cells in adhesion to cell‐derived extracellular matrix and titanium: Comparative kinome profile analysis
por: Baroncelli, Marta, et al.
Publicado: (2018)

Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant – a pilot study
por: Visseren, Thijmen, et al.
Publicado: (2020)

Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
por: Crooks, Benjamin, et al.
Publicado: (2020)

Effect of obesity on vedolizumab response in inflammatory bowel disease
por: Levine, Louis J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ii80t86s1qo05gv3asc9tmj4a